[Illinois] Biophotonics 2012: Chemical Imaging for Cancer Pathology
Licensed under Creative Commons.
Category
Published on
Abstract
Bio
Michael was part of the group from 2008-2013 and joined the University of Illinois from Lancaster University (United Kingdom) where he received his BSc in Biomedical Sciences (Hons. 1) and a Ph.D. in infrared spectroscopy for cancer and stem cell identification. Michael joined the University of Illinois from Lancaster University (United Kingdom) where he received his BSc in Biomedical Sciences (Hons. 1) and a Ph.D. in infrared spectroscopy for cancer and stem cell identification. Michael was the first-ever Carle Foundation Hospital - Beckman Institute Fellow from 2008 to 2011 and has continued a postdoctoral researcher in the Beckman Institute, Walsh's research plan focuses on advancing non-invasive cancer detection methods. His goals include finding ways to use imaging to automate the examination and classification of tissue in order to overcome many of the limitations that exist in current pathology methodologies. This could eventually reduce the time-consuming nature of diagnosis and it could also eliminate the operator bias that can lead to misdiagnosis. His research focuses on the automated classification of breast and prostate tissue microarrays for cancer diagnosis and toward developing infrared spectroscopy as a novel prognostic tool. Other research interests involve developing infrared spectroscopy for monitoring model cell systems.
(Source:http://www.chemimage.illinois.edu/personnel.html)
Cite this work
Researchers should cite this work as follows:
Submitter
University of Illinois at Urbana-Champaign